Study type

Study type

Non-interventional study

Scope of the study

Disease epidemiology
Drug utilisation
Effectiveness study (incl. comparative)
Non-interventional study

Non-interventional study design

Cohort
Other

Non-interventional study design, other

Observational, non-interventional retrospective patient chart review study
Study drug and medical condition

Medical condition to be studied

Pulmonary arterial hypertension
Pulmonary hypertension
Population studied

Age groups

  • Adult and elderly population (≥18 years)
    • Adults (18 to < 65 years)
      • Adults (18 to < 46 years)
      • Adults (46 to < 65 years)
    • Elderly (≥ 65 years)
      • Adults (65 to < 75 years)
      • Adults (75 to < 85 years)
      • Adults (85 years and over)

Estimated number of subjects

450
Study design details

Main study objective

The primary aim is to investigate the real-life patient characteristics, treatment patterns and clinical outcomes of PAH and CTEPH patients in Finland

Outcomes

1. Patient characteristics and risk groups as defined by ESC/ERS risk assessment parameters. 2. Used treatments and treatment pathways (e.g. procedures, medication, posology, treatment duration, switch patterns or discontinuation incl. possible reason). Outcomes (e.g. annualized resource use) and treatment effects defined as comparing assessments at diagnosis of PAH (baseline) and at follow-ups (potential differentiation between ERAs as derived outcomes).

Data analysis plan

Analysis will include basic statistical analysis methods aimed to describe the results. More advanced methods (e.g. multivariate modelling) may be used and subgroup analysis can be performed, if sample size and information collected is enough for such analysis. Reporting of all data is conditional of having enough observations (absolute minimum is 5 observations).